Study: ADT, radiotherapy possibly reduce bladder cancer risk

Both androgen deprivation therapy (ADT) and radiation therapy (RT) are associated with a reduced risk of secondary bladder cancer in prostate cancer (PCa) patients, according to a new study presented at the 2016 Genitourinary Cancers Symposium in San Francisco.

Renal & Urology News